Clinical Trials
9 trialsNCT02297698 2023-12-12
HER3+
Cancer Insight, LLC
Phase 2 Completed
NCT01570036 2020-12-02
Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Cancer Insight, LLC
Phase 2 Completed
NCT00088413 2019-04-16
PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00254592 2019-02-28
Neoadjuvant Treatment of Breast Cancer
University of California, Irvine
Phase 2 Completed
NCT00256243 2018-03-02
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
University of California, Irvine
Phase 2 Completed
NCT00003199 2017-07-12
Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT00791037 2017-05-25
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
University of Washington
Phase 1/2 Completed
NCT00179309 2014-07-15
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00429104 2012-12-06
Herceptin and GM-CSF for Metastatic Breast Cancer
M.D. Anderson Cancer Center
Phase 2 Completed